Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Transalta (TACPF) EBT (2016 - 2025)

Historic EBT for Transalta (TACPF) over the last 17 years, with Q3 2025 value amounting to -$38.5 million.

  • Transalta's EBT fell 68358.81% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.5 million, marking a year-over-year decrease of 15682.17%. This contributed to the annual value of $233.0 million for FY2024, which is 6427.66% down from last year.
  • According to the latest figures from Q3 2025, Transalta's EBT is -$38.5 million, which was down 68358.81% from -$95.0 million recorded in Q2 2025.
  • Over the past 5 years, Transalta's EBT peaked at $337.9 million during Q3 2023, and registered a low of -$350.3 million during Q3 2021.
  • In the last 5 years, Transalta's EBT had a median value of $16.6 million in 2021 and averaged $42.6 million.
  • As far as peak fluctuations go, Transalta's EBT surged by 135852.7% in 2022, and later tumbled by 77869.96% in 2023.
  • Over the past 5 years, Transalta's EBT (Quarter) stood at -$25.4 million in 2021, then skyrocketed by 120.31% to $5.2 million in 2022, then crashed by 778.7% to -$35.0 million in 2023, then crashed by 45.71% to -$51.0 million in 2024, then increased by 24.51% to -$38.5 million in 2025.
  • Its EBT stands at -$38.5 million for Q3 2025, versus -$95.0 million for Q2 2025 and $49.0 million for Q1 2025.